Trial Profile
Phase II study of OMS-405 in patients with opioid addiction
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs OMS 405 (Primary)
- Indications Drug dependence; Opioid-related disorders
- Focus Therapeutic Use
- 02 Nov 2016 According to an Omeros media release, the company announced results from this trial evaluating the effects of OMS-405 in heroin-dependent subjects.
- 30 Jan 2016 New trial record